Document Detail


The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.
MedLine Citation:
PMID:  17039509     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The StarClose Vascular Closure System (Abbott Vascular, Redwood City, CA) features a nitinol clip that is designed to achieve closure of the femoral arteriotomy access site. The CLIP Study was performed to assess the safety and efficacy of StarClose when compared with standard manual compression following 5-6 French diagnostic or interventional percutaneous procedures. A substudy of this trial was designed to assess the utility of duplex ultrasonography to assess patency of the femoral artery and to determine access site complications (pseudoaneurysm, arteriovenous fistula, hematoma, deep vein thrombosis) in a multicenter prospective trial. This is the report of the duplex ultrasound (DUS) substudy of the CLIP trial. METHODS: A total of 17 U.S. sites enrolled 596 subjects with 483 subjects randomized at a 2:1 ratio to receive StarClose or manual compression of the arteriotomy after a percutaneous procedure. The study included roll-in (n = 113), diagnostic (n = 208), and interventional (n = 275) arms with a primary safety endpoint of major vascular complications through 30 days and a primary efficacy endpoint of postprocedure time to hemostasis. A substudy of the CLIP interventional arm evaluated DUS images of the closure site at five study sites, targeting 100 subjects at day 30 following hemostasis. The DUS protocol was devised and implemented by an independent vascular ultrasound core laboratory with extensive experience in vascular device trials. DUS inguinal region from 6 cm proximal to 6 cm distal to the arteriotomy puncture was performed. A qualitative examination was performed to determine the presence of iatrogenic vascular injuries: hematoma, pseudoaneurysm (PSA), arteriovenous fistula (AVF), and arterial/venous thrombosis or stenosis using 2-dimensional gray scale, color, and focused Doppler images. RESULTS: DUS of 96 subjects randomized to StarClose (n = 71) and compression (n = 25) were performed and evaluated. There was no evidence of hematoma, PSA, or AVF observed in the StarClose group. No StarClose subjects in the substudy had a PSA or AVF. All patients in the substudy demonstrated patency of the access site artery and vein without thrombosis or stenosis. Finally, in the entire study cohort, no clinically-driven DUS studies demonstrated iatrogenic vascular injury or vessel thrombosis in the StarClose treated patients. CONCLUSION: DUS, a safe and reliable method for determining the safety and efficacy of access site closure devices, is a reliable, safe, inexpensive and accurate method of assessing vascular access site complications in multicenter trials. In this substudy of the CLIP study, DUS found no statistical difference in access site complications between the StarClose and manual compression groups. Both groups maintained vessel patency without stenosis, thrombosis, hematoma, pseudoaneurysm, or AV fistula.
Authors:
M R Jaff; G Hadley; J B Hermiller; C Simonton; T Hinohara; L Cannon; M Reisman; G Braden; D R Fletcher; M Zapien; T M Chou; K DiDonato
Related Documents :
17548259 - Hemoperitoneum secondary to rupture of cystic artery pseudoaneurysm.
11128459 - Treatment of femoral artery pseudoaneurysms with percutaneous thrombin injection.
1387569 - Treatment of hemodialysis fistula pseudoaneurysms with detachable balloons: technique a...
19220939 - The management of multi-site, bleeding, visceral artery pseudoaneurysms, secondary to n...
18455649 - Endovascular treatment of postlaminectomy aortic pseudoaneurysm.
19917559 - Iatrogenic pseudoaneurysm of the superior gluteal artery presenting as pelvic mass with...
6642499 - Closure of membranous ventricular septal defect of heart by septal leaflet of tricuspid...
25080469 - Spontaneous dissecting lenticulostriate artery aneurysm in children: radiologic finding...
10522829 - New technique for vagal nerve stimulation.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  68     ISSN:  1522-1946     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-31     Completed Date:  2007-06-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  684-9     Citation Subset:  IM    
Copyright Information:
(c) 2006 Wiley-Liss, Inc.
Affiliation:
VasCore, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. mjaff@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Alloys
Aneurysm, False / etiology,  ultrasonography
Arterial Occlusive Diseases / etiology,  ultrasonography
Arteriovenous Fistula / etiology,  ultrasonography
Collateral Circulation
Equipment Design / instrumentation
Equipment Safety / instrumentation
Female
Femoral Artery / surgery,  ultrasonography
Femoral Vein / surgery,  ultrasonography
Follow-Up Studies
Heart Catheterization / instrumentation*
Hematoma / etiology,  ultrasonography
Hemostasis
Hemostatic Techniques / instrumentation*
Humans
Male
Middle Aged
Postoperative Complications / etiology,  ultrasonography
Prospective Studies
Reproducibility of Results
Saphenous Vein / surgery,  ultrasonography
Surgical Instruments* / adverse effects
Treatment Outcome
Ultrasonography, Doppler, Duplex*
Ultrasonography, Interventional*
Vascular Patency
Venous Thrombosis / etiology,  ultrasonography
Chemical
Reg. No./Substance:
0/Alloys; 52013-44-2/nitinol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The StarClose Vascular Closure System: interventional results from the CLIP study.
Next Document:  Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated co...